US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about NASDAQ:NKGN

Recent news which mentions NASDAQ:NKGN

NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024
Tickers NKGN
Tags Market News Earnings Reports NKGN
From InvestorPlace
NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023
Tickers NKGN
Tags Earnings Reports Market News NKGN
From InvestorPlace
Why Is NKGen Biotech (NKGN) Stock Up 62% Today?
Tickers NKGN
Tags Today's Market Market News NKGN
From InvestorPlace
Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct
NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct